Skip to main content
main-content

Type 2 diabetes

Free registration

Medicine Matters is developed for healthcare professionals as

a premier resource for the latest clinical information in medicine.

medwireNews top story

Cardioprotective benefits of dapagliflozin extend beyond people with diabetes

Heart failure

Treatment with dapagliflozin is associated with a significant reduction in the risk for heart failure worsening or cardiovascular death in people with heart failure and reduced ejection fraction regardless of whether or not they have diabetes, shows an exploratory analysis of DAPA-HF trial data.

medwireNews top story

Diabetes medication changes at hospital discharge of older adults often not beneficial

Doctor_hospital bed

Older adults with type 2 diabetes often receive diabetes medication adjustments at hospital discharge that may be of little or no benefit, study results suggest.

medwireNews top story

Liraglutide 3.0 mg boosts weight loss in insulin-dependent type 2 diabetes

Insulin pens

Adding liraglutide 3.0 mg to intensive behavioral therapy increases weight loss in overweight or obese people with insulin-treated type 2 diabetes, results of the phase 3 SCALE Insulin trial show.

medwireNews top story

Urgent action needed to improve dysglycemia screening in patients with heart disease

HbA1c

More than half of people with coronary artery disease have impaired glucose tolerance, yet many are unaware of this or are undertreated despite knowledge of their condition, results of the EUROASPIRE V survey show.

medwireNews top story

Diagnosis age enhances predictive power of family diabetes history

Portrait of three generations male family members together

The risk associated with a family history of type 2 diabetes is highest for people whose near relatives were diagnosed with the condition at a young age, show registry data.

medwireNews top story

‘Early therapeutic window’ highlighted for LADA

Open window

Optimal glycemic control during the first years after a latent autoimmune diabetes of adulthood diagnosis could prevent people’s microvascular complication risk from equaling that seen in those with type 2 diabetes, shows an analysis of the UKPDS.

medwireNews top story

Haptoglobin genotype may dictate success of intensive glucose control

Blood test

The benefits and harms of intensive glucose control in people with type 2 diabetes may depend on which form of haptoglobin they have, shows an analysis of the ACCORD trial.

medwireNews top story

About 50% attain type 2 glycemic targets with glargine 300 in real-world

Mature man injecting insulin in his abdomen

Initiating insulin glargine 300 U/mL could help half of those patients whose type 2 diabetes is inadequately controlled with oral antidiabetic medication to achieve their personal glycemic target within a year, real-world data suggest.

medwireNews top story

Weight gain blunts benefits of quitting smoking in type 2 diabetes

Discarded cigarette butts

Gaining weight after stopping smoking attenuates the cardiovascular disease benefits of quitting in people with type 2 diabetes, but does not appear to lessen its positive effect on mortality, shows research.

medwireNews top story

Lower gout risk with SGLT2 inhibitors vs GLP-1 receptor agonists

Gout

People with type 2 diabetes who are treated with sodium-glucose cotransporter 2 inhibitors are less likely to develop gout than those given glucagon-like peptide-1 receptor agonists, researchers report.

medwireNews top story

CVD-REAL 3: Renal benefits of SGLT2 inhibitors confirmed in real-world study

Kidneys

Patients with type 2 diabetes who are treated with SGLT2 inhibitors in routine clinical practice have a lower rate of kidney function decline and a reduced risk for adverse renal events compared with those given other glucose-lowering drugs, researchers report.

medwireNews top story

‘Upskilling’ healthcare providers could address concerns of people with diabetes

Patient in healthcare consultation

A large survey has uncovered a number of issues that particularly frustrate people with diabetes during their interactions with their healthcare providers.

medwireNews top story

Nonalbuminuric CKD risks confirmed in type 2 diabetes

Heart kidney and nerves

People with type 2 diabetes and reduced kidney function in the absence of albuminuria have an increased risk for mortality and major adverse cardiovascular events, despite a low risk for end-stage renal disease, research shows.

medwireNews top story

Prediabetes not an immediate mortality concern in older adults

Doctor checking blood sugar of senior patient

Prediabetes has no effect on the short-term mortality risk of older adults, suggests an analysis of the Atherosclerosis Risk in Communities study.

medwireNews top story

Preoperative diabetes duration may affect remission rates after bariatric surgery

Bariatric surgery

Swedish research suggests that determining type 2 diabetes duration prior to bariatric surgery could help prioritize those patients most likely to achieve diabetes remission.

Online coaching helps with weight loss maintenance

Electronic health records

People who are trying to maintain weight loss with the help of electronic health records-based tracking tools do significantly better if they are given access to an online coach, shows a randomized trial.

Patient case study

Diabetes treatment in the elderly: A multi-morbid patient case study

Elderly woman with medication (symbolic image with model)

Primary care physician Jay Shubrook shares his recommendations for diabetes management in a 72-year-old, multi-morbid patient.

Get more on: Older adults with type 2 diabetes | Diabetes comorbidities

medwireNews top story

Trial results support gastric bypass as ‘procedure of choice’ for diabetes remission

Gastric bypass surgery (used with permission)

People with obesity and type 2 diabetes who undergo gastric bypass surgery have higher rates of diabetes remission after 1 year than those undergoing sleeve gastrectomy, indicate findings from the Oseberg trial.

Expert opinion editorial

The family and diabetes care: A multifaceted relationship

Mother helps son check blood sugar

Sanjay Kalra discusses the World Diabetes Day theme, and evaluates the concerns and opportunities presented by “The Family and Diabetes”.

medwireNews top story

Further support for early combination therapy in type 2 diabetes

VERIFY trial results

Adding the DPP-4 inhibitor sitagliptin to first-line metformin therapy may delay the need for exogenous insulin among people with type 2 diabetes, researchers report.

12-17-2019 | Insulin | Editorial | Article

How can we optimize titration with new basal insulins?

Nurse and Diabetes Educator Lori Berard highlights the advantages of “concentrated” insulins and outlines her recommendations for getting titration right for patients.

11-27-2019 | Nephropathy | Video | Article

The revolution is here: New treatments for diabetic kidney disease

WATCH | Katherine Tuttle and Jay Shubrook reconvene to discuss what the landmark findings from recent renal outcomes trials mean for clinical practice (16:51).

11-06-2019 | Older adults | Case study | Article

Diabetes treatment in the elderly: Kathryn

Primary care physician Jay Shubrook shares his recommendations for diabetes management in a 72-year-old, multi-morbid patient.

Diagnosis and management of prediabetes: a consensus of GCC countries

Guidance based on outcomes of an advisory board of diabetes experts, for healthcare professionals addressing the diagnosis and treatment of prediabetes.

This interactive roadmap is intended for healthcare professionals practicing in Saudi Arabia, Kuwait, the United Arab Emirates, Qatar, Bahrain, and Oman. 

Funding for this roadmap was provided by Merck Serono Middle East FZ-LLC

Access the interactive roadmap

Downloadable slides

10-31-2018 | Slideset | Collection

FreeStyle Libre collection

These slide sets summarize the results of randomized controlled trials investigating the use of flash glucose-sensing technology in patients with diabetes.

Funded by an educational grant from Abbott Diabetes Care

Themed collections

06-25-2018 | SGLT2 inhibitors | Themed collection | Collection

Sodium-glucose cotransporter-2 inhibitors in type 2 diabetes

An updated collection of articles focusing on the mechanism of action and clinical use of sodium-glucose cotransporter-2 inhibitors in patients with diabetes.

Journal articles and book chapters

Guidelines

A convenient single access point, providing diabetes professionals with links to a comprehensive set of clinical practice guidelines from a wide range of relevant organizations.

Slides

Downloadable PowerPoint slide sets containing a variety of high-quality images and illustrations from Springer Nature’s library of published figures.

Practice tips

Practical information, guidance, and helpful resources for diabetes healthcare providers. Comprised of practical approaches, case studies, and more.

Themed collections

Compendia of selected, recently published, free full-text journal and book content from Springer Nature and other publishers on a particular topic within diabetes management, as recommended by our Editorial Board.

Independent Medical Education

Educational programs building upon the most current research and professional practice recommendations, with the aim of enabling more efficient diagnosis, optimizing treatment, and improving patient outcomes.

ADVERTISEMENT

Flash glucose monitoring technology

Downloadable slide sets from key clinical trials in people with diabetes

Image Credits